Maintenance of the contractile phenotype in corpus cavernosum smooth muscle cells by Myocardin gene therapy ameliorates erectile dysfunction in bilateral cavernous nerve injury rats.

MLA

Zhang, H. B., et al. “Maintenance of the Contractile Phenotype in Corpus Cavernosum Smooth Muscle Cells by Myocardin Gene Therapy Ameliorates Erectile Dysfunction in Bilateral Cavernous Nerve Injury Rats.” Andrology, vol. 5, no. 4, July 2017, pp. 798–806. EBSCOhost, https://doi.org/10.1111/andr.12375.

APA

Zhang, H.-B., Wang, Z.-Q., Chen, F.-Z., Ding, W., Liu, W.-B., Chen, Z.-R., He, S.-H., & Wei, A.-Y. (2017). Maintenance of the contractile phenotype in corpus cavernosum smooth muscle cells by Myocardin gene therapy ameliorates erectile dysfunction in bilateral cavernous nerve injury rats. Andrology, 5(4), 798–806. https://doi.org/10.1111/andr.12375

Chicago

Zhang, H-B, Z-Q Wang, F-Z Chen, W Ding, W-B Liu, Z-R Chen, S-H He, and A-Y Wei. 2017. “Maintenance of the Contractile Phenotype in Corpus Cavernosum Smooth Muscle Cells by Myocardin Gene Therapy Ameliorates Erectile Dysfunction in Bilateral Cavernous Nerve Injury Rats.” Andrology 5 (4): 798–806. doi:10.1111/andr.12375.